Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories is currently trading at Rs. 5627.20, down by 36.05 points or 0.64% from its previous closing of Rs. 5663.25 on the BSE.

The scrip opened at Rs. 5689.95 and has touched a high and low of Rs. 5689.95 and Rs. 5611.85 respectively. So far 4288 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5986.20 on 24-Aug-2023 and a 52 week low of Rs. 4176.85 on 25-Jan-2023.

Last one week high and low of the scrip stood at Rs. 5729.15 and Rs. 5544.25 respectively. The current market cap of the company is Rs. 94417.26 crore.

The promoters holding in the company stood at 26.66%, while Institutions and Non-Institutions held 49.23% and 10.09% respectively.

Dr. Reddy's Laboratories' unit -- Dr. Reddy's Laboratories, Inc. is recalling 1,656 bottles of Montelukast sodium tablets in the US market for manufacturing issues. The product is indicated to prevent wheezing, breathing difficulty, chest tightness, and coughing caused by asthma in adults.

As per the US Food and Drug Administration (USFDA), the company is recalling the affected lot due to ‘the presence of foreign tablets and capsules’. A foreign tablet was found in a bottle of Montelukast sodium tablets, USP 10mg, identified as metoprolol 25 mg.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.